Agios Pharmaceuticals, Inc

(NASDAQ:AGIO)

Latest On Agios Pharmaceuticals, Inc (AGIO):

Date/Time Type Description Signal Details
2023-05-24 13:19 ESTNewsAgios Pharmaceuticals: Good Execution, A Good Deal Of Cash, Some HurdlesN/A
2023-05-04 22:01 ESTNewsAgios Pharmaceuticals, Inc. 2023 Q1 - Results - Earnings Call PresentationN/A
2023-05-04 22:01 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) Q1 2023 Earnings Call TranscriptN/A
2023-05-04 09:00 ESTNewsAgios Pharmaceuticals GAAP EPS of -$1.47 beats by $0.23, revenue of $5.6M beats by $0.37MN/A
2023-05-03 20:46 ESTNewsAgios Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-02-24 01:00 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) Q4 2022 Earnings Call TranscriptN/A
2023-02-23 11:31 ESTNewsAgios Pharmaceuticals GAAP EPS of -$4.23 beats by $2.06, revenue of $14.24M beats by $0.35MN/A
2023-02-22 09:46 ESTNewsAgios Pharma: Multiple Growth Catalysts If Pyrukynd Conversions Pull ThroughN/A
2023-01-11 19:46 ESTNewsAgios Pharmaceuticals (AGIO) presents at 41st Annual J.P. Morgan Healthcare Conference - SlideshowN/A
2022-12-12 09:07 ESTNewsAgios rare blood disorder drug Pyrukynd sustains benefits in patients in long term dataN/A
2022-11-17 17:06 ESTNewsAgios Pharmaceuticals upgraded to neutral at Goldman Sachs on Pyrukynd outlookN/A
2022-11-12 00:39 ESTNewsAgios granted EU approval for Pyrukynd in pyruvate kinase deficiencyN/A
2022-11-04 15:26 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) Q3 2022 Earnings Call TranscriptN/A
2022-11-04 15:26 ESTNewsAgios Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call PresentationN/A
2022-11-03 22:53 ESTNewsAgios Pharmaceuticals GAAP EPS of -$1.49 beats by $0.27, revenue of $3.52M misses by $1.72MN/A
2022-10-30 23:18 ESTNewsAgios Pharmaceuticals: A Big Year On The HorizonN/A
2022-10-27 21:23 ESTNewsAgios sells its rights to royalties on U.S. sales of cancer drug Tibsovo for $131.8MN/A
2022-09-19 18:38 ESTNewsAgios appoints Cecilia Jones as finance chiefN/A
2022-09-16 22:56 ESTNewsAgios Pyrukynd for rare blood disorder gets EMA panel backing for approval in EUN/A
2022-09-07 13:53 ESTNewsAgios CFO Jonathan Biller to quitN/A
2022-09-01 18:52 ESTNewsAgios adds more than 13% after Novo deal to acquire rival FormaN/A
2022-08-07 19:20 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) CEO Jackie Fouse on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-07 19:20 ESTNewsAgios Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-04 23:04 ESTNewsAgios stock rises as Q2 sees new drug Pyrukynd bring in revenueN/A
2022-08-04 07:32 ESTNewsAgios Pharmaceuticals GAAP EPS of -$1.68 beats by $0.07N/A
2022-07-27 15:35 ESTNewsAgios gains as blood disorder therapy draws positive viewsN/A
2022-07-26 12:48 ESTNewsAgios Pharmaceuticals Is A Buy On Coming Revenue RampN/A
2022-07-12 22:36 ESTNewsAgios Pharmaceuticals hires new CEON/A
2022-07-12 22:36 ESTNewsAgios Pharmaceuticals appoints new board chair, CEON/A
2022-06-18 02:50 ESTNewsAgios Pharmaceuticals (AGIO) Presents At EHA 2022 Conference - SlideshowN/A
2022-05-18 02:34 ESTNewsAgios chief scientific officer to depart amid layoffs as company pivots to genetic diseasesN/A
2022-05-10 23:23 ESTNewsAgios: Approved Product, Upcoming CatalystsN/A
2022-05-10 01:38 ESTNewsAgios Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-05 20:57 ESTNewsAgios Pharmaceuticals GAAP EPS of -$1.74 beats by $0.07, revenue of $0.83M misses by $1.88MN/A
2022-05-05 20:57 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) CEO Jackie Fouse on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-04 22:11 ESTNewsAgios Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-02-25 04:07 ESTNewsAgios Pharmaceuticals, Inc. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-02-25 04:06 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) CEO Jackie Fouse on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-24 08:21 ESTNewsAgios Pharmaceuticals Q4 2021 Earnings PreviewN/A
2022-02-24 08:20 ESTNewsAgios Pharmaceuticals GAAP EPS of -$1.81 misses by $0.12N/A
2022-02-23 12:21 ESTNewsAgios Pharmaceuticals With FDA Approval Is A BuyN/A
2022-02-19 06:37 ESTNewsAgios Pharmaceuticals' mitapivat approved by FDA for pyruvate kinase deficiencyN/A
2022-02-19 06:36 ESTNewsAgios vindicated with FDA approval for Pyrukynd - H.C. WainwrightN/A
2022-02-18 08:40 ESTNewsAgios Pyrukynd for rare blood disorder gets US FDA approvalN/A
2022-01-20 15:39 ESTNewsAgios Before The February PDUFAN/A
2021-12-14 09:40 ESTNewsAgios presents mitapivat long-term data in PK deficiency at ASH 2021N/A
2021-11-04 03:28 ESTNewsAgios Pharmaceuticals, Inc. (AGIO) CEO Dr. Jackie Fouse on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-04 03:28 ESTNewsAgios Pharmaceuticals, Inc. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-03 07:29 ESTNewsAgios Pharmaceuticals EPS beats by $1.46N/A
2021-11-02 11:38 ESTNewsAgios Pharmaceuticals Q3 2021 Earnings PreviewN/A

About Agios Pharmaceuticals, Inc (AGIO):

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers TIBSOVO (ivosidenib), an oral targeted inhibitor for treating adult patients with relapsed or refractory acute myeloid leukemia (R/R AML), as well as to treat patients with newly diagnosed AML; and IDHIFA (enasidenib), an oral targeted inhibitor for patients with R/R AML and an isocitrate dehydrogenase 2 mutation. It is also developing TIBSOVO, which has completed Phase II clinical trials to treat IC eligible frontline AML; that is in Phase III clinical trials for treating IC ineligible frontline AML; and that is in Phase III clinical trials for the treatment of cholangiocarcinoma, as well as in early stage clinical development to treat glioma and solid tumors. In addition, the company is developing IDHIFA, which has completed Phase II clinical study for treating IC eligible frontline AML; and that is in Phase I/II clinical trials for the treatment of IC ineligible frontline AML. Further, it is developing mitapivat, which is in Phase III clinical trials to treat pyruvate kinase deficiency, as well as in Phase II clinical study for treating thalassemia and sickle cell disease; vorasidenib (AG-881) that is in Phase I clinical trials for the treatment of solid tumors, including glioma; AG-270, which is in Phase I dose-escalation trial to treat methylthioadenosine phosphorylase deleted tumors; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is based in Cambridge, Massachusetts.

AGIO Quotes by TradingView

See Advanced Chart

General

  • Name Agios Pharmaceuticals, Inc
  • Symbol AGIO
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 562
  • Fiscal Year EndDecember
  • IPO Date2013-07-24
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.agios.com
View More

Valuation

  • Forward PE 8.1
  • Price/Sales (Trailing 12 Mt.) 17.51
  • Price/Book (Most Recent Quarter) 8.98
  • Enterprise Value Revenue 15.36
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$6.07
  • Next Year EPS Estimate -$6.10
  • Next Quarter EPS Estimate -$1.29
  • Profit Margin -161%
  • Operating Margin -156%
  • Return on Assets -23%
  • Return on Equity -63%
  • Revenue 203.2 million
  • Earnings Per Share -$6.67
  • Revenue Per Share $2.95
  • Gross Profit -167079000
  • Quarterly Earnings Growth 24.3%
View More

Highlights

  • Market Capitalization 3.38 billion
  • EBITDA -399112000
  • PE Ratio 1.63
  • Analyst Target Price $64.89
  • Book Value Per Share $5.77
View More

Share Statistics

  • Shares Outstanding 69.36 million
  • Shares Float 61.75 million
  • % Held by Insiders 1133%
  • % Held by Institutions 92.34%
  • Shares Short 5.82 million
  • Shares Short Prior Month 5.68 million
  • Short Ratio 8.4
  • Short % of Float 11%
  • Short % of Shares Outstanding 8%
View More

Technicals

  • Beta 1.62
  • 52 Week High $58.93
  • 52 Week Low $32.47
  • 50 Day Moving Average 50.87
  • 200 Day Moving Average 42.95
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Agios Pharmaceuticals, Inc (AGIO) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Agios Pharmaceuticals, Inc (AGIO) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$44.05 million-$1.41-$1.31-7.96%
2020-09-302020-11-05$34.71 million-$1.43-$1.36-5.47%
2020-06-302020-07-30$N/A-$1.31-$1.363.72%
2020-03-312020-04-30$N/A-$0.59-$1.6463.94%
2019-12-312020-02-13$35.44 million-$1.60-$1.684.94%
2019-09-302019-10-31$26.02 million-$1.81-$1.81-0.22%
2019-06-302019-08-01$26.22 million-$1.87-$1.70-9.89%
2019-03-312019-05-02$30.23 million-$1.59-$1.759.24%
2018-12-312019-02-14$30.01 million-$1.58-$1.664.62%
2018-09-302018-11-01$15.2 million-$1.63-$1.62-0.73%
2018-06-302018-08-02$40.41 million-$1.19-$1.5523.07%
2018-03-312018-05-04$8.76 million-$1.63-$1.651.41%
2017-12-312018-02-14$9.8 million-$1.81-$1.61-12.63%
2017-09-302017-11-01$11.36 million-$1.59-$1.7810.46%
2017-06-302017-08-08$11.35 million-$1.78-$1.57-13.53%
2017-03-312017-05-04$10.51 million-$1.56-$1.8013.19%
2016-12-312017-02-16$22.65 million-$1.34-$1.5111.38%
2016-09-302016-11-03$8.99 million-$1.63-$1.51-8.2%
2016-06-302016-08-04$6.98 million-$1.47-$1.30-12.77%
2016-03-312016-05-05$31.28 million-$0.61-$0.9334.47%
2015-12-312016-02-18$6.22 million-$1.08-$0.53-102.21%
2015-09-302015-11-05$5.48 million-$1.07-$0.88-21.59%
2015-06-302015-08-06$13.22 million-$0.85-$0.46-84.78%
2015-03-312015-05-07$34.2 million-$0.13-$0.9285.87%
2014-12-312015-02-17$14.64 million-$0.76-$0.58-31.03%
2014-09-302014-11-07$33.9 million$0.10-$0.52119.23%
2014-06-302014-08-07$8.41 million-$0.54-$0.40-35%
2014-03-312014-05-08$8.41 million-$0.39-$0.37-5.41%
2013-12-312014-03-06$6.74 million-$0.40-$0.34-17.65%
2013-09-302013-11-07$6.27 million-$0.47-$0.29-62.07%
2013-06-302013-09-05$6.27 million-$2.80-$0.32-775%

Agios Pharmaceuticals, Inc (AGIO) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Agios Pharmaceuticals, Inc (AGIO) Chart:

Agios Pharmaceuticals, Inc (AGIO) News:

Below you will find a list of latest news for Agios Pharmaceuticals, Inc (AGIO) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Agios Pharmaceuticals, Inc (AGIO) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-02-2012.50CALL0 00TRUE00
2026-02-20150CALL0 00TRUE00
2026-02-2017.511.91CALL0 2763.26TRUE00
2026-02-20206.2CALL0 763.67TRUE00
2026-02-2022.56.4CALL0 5567.55TRUE00
2026-02-20253.75CALL0 7254.1TRUE00
2026-02-20300.8CALL20 181561.41FALSE-0.3-0.27
2026-02-20350.19CALL45 87163.91FALSE-0.21-0.53
2026-02-20400.22CALL0 1005987.17FALSE00
2026-02-20450.19CALL0 166119.05FALSE00
2026-02-20500.31CALL0 45220.85FALSE00
2026-02-205512.14CALL0 55339.21FALSE00
2026-02-20600.05CALL0 218356.4FALSE00
2026-02-20650.15CALL0 1371.7FALSE00
2026-02-2012.50PUT0 0525.8FALSE00
2026-02-20150PUT0 0431.74FALSE00
2026-02-2017.50.2PUT0 139145.53FALSE00
2026-02-20200.25PUT6 4778.2FALSE0.070.39
2026-02-2022.50.5PUT30 26967.56FALSE0.050.11
2026-02-20251.1PUT72 20461.6FALSE1.10
2026-02-20303.3PUT0 37840.82TRUE00
2026-02-20356.3PUT0 3060.06TRUE00
2026-02-204012.92PUT0 00TRUE00
2026-02-204517.2PUT0 00TRUE00
2026-02-205016.9PUT0 0123.45TRUE00
2026-02-205520.6PUT0 0138.08TRUE00
2026-02-206024.2PUT0 0151.18TRUE00
2026-02-20650PUT0 0163.07TRUE00
2026-03-20150CALL0 0101.65TRUE00
2026-03-2017.50CALL0 081.46TRUE00
2026-03-20200CALL0 060.08TRUE00
2026-03-2022.50CALL0 061.32TRUE00
2026-03-20254.22CALL0 658.85TRUE00
2026-03-20302.3CALL0 494.73FALSE00
2026-03-20350.55CALL1 061.79FALSE0.550
2026-03-20400CALL0 0139.39FALSE00
2026-03-20150PUT0 0313.85FALSE00
2026-03-2017.50PUT0 0259.93FALSE00
2026-03-20200PUT0 0214.75FALSE00
2026-03-2022.50.65PUT0 1117.18FALSE00
2026-03-20250PUT0 078.39FALSE00
2026-03-20304.6PUT0 157.15TRUE00
2026-03-20358.1PUT0 166.56TRUE00
2026-03-20400PUT0 058.1TRUE00
2026-05-1512.513.2CALL0 1488.12TRUE00
2026-05-15150CALL0 067.75TRUE00
2026-05-1517.511.55CALL0 273.77TRUE00
2026-05-15209CALL0 1267.2TRUE00
2026-05-1522.57.72CALL0 1364.26TRUE00
2026-05-15255.2CALL0 37864.39TRUE00
2026-05-15303.68CALL0 55879.55FALSE00
2026-05-15352CALL1 37673.68FALSE20
2026-05-15401.15CALL0 86181.4FALSE00
2026-05-15450.95CALL0 97113.03FALSE00
2026-05-15502.25CALL0 43123.79FALSE00
2026-05-15550.77CALL0 15175.24FALSE00
2026-05-15601.15CALL0 22184.19FALSE00
2026-05-15650.45CALL0 9168.91FALSE00
2026-05-1512.50.75PUT0 1155.2FALSE00
2026-05-15150PUT0 0122.66FALSE00
2026-05-1517.52PUT0 180.01FALSE00
2026-05-15201.5PUT0 32476.43FALSE00
2026-05-1522.51.8PUT0 7558.45FALSE00
2026-05-15252.7PUT0 8871.13FALSE00
2026-05-15305.4PUT3 52858.6TRUE0.150.03
2026-05-15358.8PUT0 46860.12TRUE00
2026-05-154016.4PUT0 4762.16TRUE00
2026-05-154514.3PUT0 456.32TRUE00
2026-05-155017.3PUT0 169.42TRUE00
2026-05-155523PUT0 073.61TRUE00
2026-05-15600PUT0 00TRUE00
2026-05-15650PUT0 00TRUE00
2026-08-21150CALL0 082.35TRUE00
2026-08-2117.50CALL0 081.3TRUE00
2026-08-212012.7CALL0 277.1TRUE00
2026-08-2122.50CALL0 079.32TRUE00
2026-08-21250CALL0 076.62TRUE00
2026-08-21300CALL0 079.24FALSE00
2026-08-21354.6CALL0 176.24FALSE00
2026-08-21401.75CALL2 2961.62FALSE1.750
2026-08-21452.4CALL0 681.25FALSE00
2026-08-21150PUT0 0167.61FALSE00
2026-08-2117.52.4PUT0 32139.12FALSE00
2026-08-21200PUT0 077.54FALSE00
2026-08-2122.50PUT0 074.38FALSE00
2026-08-21254.3PUT0 3176.7FALSE00
2026-08-21309.6PUT0 8476.44TRUE00
2026-08-213512.5PUT0 2675.33TRUE00
2026-08-21400PUT0 073.54TRUE00
2026-08-21450PUT0 075.35TRUE00
2026-12-1812.50CALL0 0102.06TRUE00
2026-12-18150CALL0 0100.76TRUE00
2026-12-1817.50CALL0 0105.08TRUE00
2026-12-18208.2CALL0 499.55TRUE00
2026-12-1822.512CALL0 799.78TRUE00
2026-12-182511.1CALL0 6998.7TRUE00
2026-12-18308.3CALL0 3174999.25FALSE00
2026-12-18357.5CALL0 18296.78FALSE00
2026-12-18406.6CALL0 5897.12FALSE00
2026-12-18455.4CALL0 67100.61FALSE00
2026-12-18503.95CALL0 920100.26FALSE00
2026-12-18554.5CALL0 198.78FALSE00
2026-12-18604.2CALL0 398.89FALSE00
2026-12-18653.5CALL0 2098.21FALSE00
2026-12-1812.50PUT0 0160.38FALSE00
2026-12-18150PUT0 099.62FALSE00
2026-12-1817.50PUT0 076.38FALSE00
2026-12-18204.5PUT0 4991.04FALSE00
2026-12-1822.55.02PUT0 284.27FALSE00
2026-12-18256.5PUT0 2395.21FALSE00
2026-12-183010.6PUT0 5497.24TRUE00
2026-12-183513.2PUT0 11383.4TRUE00
2026-12-184017.4PUT0 6885.72TRUE00
2026-12-184522PUT0 6093.46TRUE00
2026-12-18500PUT0 096.26TRUE00
2026-12-18550PUT0 092.52TRUE00
2026-12-18600PUT0 092.86TRUE00
2026-12-18650PUT0 092.24TRUE00
2027-01-1512.514.45CALL0 15108.39TRUE00
2027-01-151514.1CALL0 5105.14TRUE00
2027-01-1517.50CALL0 0100.57TRUE00
2027-01-15208.44CALL0 295.29TRUE00
2027-01-1522.511.2CALL0 498.55TRUE00
2027-01-152511.25CALL0 3497.32TRUE00
2027-01-15309.2CALL0 11697.63FALSE00
2027-01-15357.9CALL0 4494.66FALSE00
2027-01-15403CALL0 3595.44FALSE00
2027-01-15456.41CALL0 2396.43FALSE00
2027-01-15504CALL0 6593.72FALSE00
2027-01-15550CALL0 094.7FALSE00
2027-01-15601.85CALL0 194.81FALSE00
2027-01-15652.05CALL0 1396.75FALSE00
2027-01-1512.50PUT0 0152.24FALSE00
2027-01-15152.35PUT0 2395.06FALSE00
2027-01-1517.50PUT0 075.13FALSE00
2027-01-15203.79PUT0 686.43FALSE00
2027-01-1522.56PUT0 60685.35FALSE00
2027-01-15257PUT1 156783.05FALSE70
2027-01-153011.2PUT0 17890.29TRUE00
2027-01-153514.5PUT0 487.29TRUE00
2027-01-15400PUT0 079.98TRUE00
2027-01-15450PUT0 092.8TRUE00
2027-01-15500PUT0 093.15TRUE00
2027-01-15550PUT0 089.59TRUE00
2027-01-15600PUT0 090.02TRUE00
2027-01-15650PUT0 089.48TRUE00
2028-01-2112.518.7CALL0 679.91TRUE00
2028-01-211516.3CALL0 1282.99TRUE00
2028-01-2117.50CALL0 078.25TRUE00
2028-01-21200CALL0 078.31TRUE00
2028-01-2122.50CALL0 077.46TRUE00
2028-01-212512.85CALL0 975.98TRUE00
2028-01-213011.76CALL0 1375.54FALSE00
2028-01-21355.8CALL0 176.95FALSE00
2028-01-21408.43CALL0 976.94FALSE00
2028-01-21457.81CALL0 179.63FALSE00
2028-01-21503.1CALL0 074.15FALSE00
2028-01-21556.7CALL0 175.03FALSE00
2028-01-21600CALL0 075.35FALSE00
2028-01-21655.21CALL0 175.21FALSE00
2028-01-2112.50PUT0 0110.07FALSE00
2028-01-21150PUT0 072.89FALSE00
2028-01-2117.50PUT0 078.67FALSE00
2028-01-21206PUT0 375.2FALSE00
2028-01-2122.57.5PUT0 277.51FALSE00
2028-01-21258.5PUT0 176.25FALSE00
2028-01-21300PUT0 077.12TRUE00
2028-01-21350PUT0 077.41TRUE00
2028-01-21400PUT0 074.2TRUE00
2028-01-214523.7PUT0 874.97TRUE00
2028-01-215027PUT0 1578.16TRUE00
2028-01-21550PUT0 076.51TRUE00
2028-01-21600PUT0 077.56TRUE00
2028-01-21650PUT0 078TRUE00

Latest AGIO Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST11$17.4
Jun 13, 2022 7:59 PM EST189$17.4
Jun 13, 2022 7:59 PM EST128$17.4
Jun 13, 2022 7:59 PM EST200$17.38
Jun 13, 2022 7:59 PM EST17$17.4

Agios Pharmaceuticals, Inc (AGIO) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520167148/0001193125-20-167148-index.htm
2019-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000021545719003331/0000215457-19-003331-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000031506619000835/0000315066-19-000835-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000031506620000791/0000315066-20-000791-index.htm
2020-08-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000031506620001684/0000315066-20-001684-index.htm
2019-10-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000083423719000203/0000834237-19-000203-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000083423720008047/0000834237-20-008047-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000090221919000091/0000902219-19-000091-index.htm
2020-01-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000090221920000008/0000902219-20-000008-index.htm
2019-01-31SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000093247119002231/0000932471-19-002231-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000093247119004832/0000932471-19-004832-index.htm
2019-11-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000110465919064171/0001104659-19-064171-index.htm
2019-11-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1439222/000110465919064173/0001104659-19-064173-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000110465920017624/0001104659-20-017624-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000110465920018297/0001104659-20-018297-index.htm
2018-11-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312518314801/0001193125-18-314801-index.htm
2018-11-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312518328948/0001193125-18-328948-index.htm
2018-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312518341083/0001193125-18-341083-index.htm
2018-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312518353307/0001193125-18-353307-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519003167/0001193125-19-003167-index.htm
2019-01-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000119312519018824/0001193125-19-018824-index.htm
2019-02-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519039198/0001193125-19-039198-index.htm
2019-02-14S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1439222/000119312519039513/0001193125-19-039513-index.htm
2019-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519051918/0001193125-19-051918-index.htm
2019-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519107805/0001193125-19-107805-index.htm
2019-04-18DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1439222/000119312519110870/0001193125-19-110870-index.htm
2019-04-18DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1439222/000119312519110887/0001193125-19-110887-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519133821/0001193125-19-133821-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519134882/0001193125-19-134882-index.htm
2019-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519148009/0001193125-19-148009-index.htm
2019-05-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519162771/0001193125-19-162771-index.htm
2019-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519164072/0001193125-19-164072-index.htm
2019-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519166109/0001193125-19-166109-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519209747/0001193125-19-209747-index.htm
2019-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519237824/0001193125-19-237824-index.htm
2019-09-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519258364/0001193125-19-258364-index.htm
2019-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519275491/0001193125-19-275491-index.htm
2019-10-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519279631/0001193125-19-279631-index.htm
2019-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519283514/0001193125-19-283514-index.htm
2019-11-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1439222/000119312519285887/0001193125-19-285887-index.htm
2019-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519288482/0001193125-19-288482-index.htm
2019-11-08424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1439222/000119312519288495/0001193125-19-288495-index.htm
2019-11-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519298670/0001193125-19-298670-index.htm
2019-12-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312519309199/0001193125-19-309199-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520005857/0001193125-20-005857-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520006338/0001193125-20-006338-index.htm
2020-02-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520034263/0001193125-20-034263-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000119312520037796/0001193125-20-037796-index.htm
2020-02-19S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1439222/000119312520041964/0001193125-20-041964-index.htm
2020-04-16DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1439222/000119312520109284/0001193125-20-109284-index.htm
2020-04-16DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1439222/000119312520109288/0001193125-20-109288-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520127627/0001193125-20-127627-index.htm
2020-04-30POSASRPost-effective Amendment to an automatic shelf registration statementhttps://www.sec.gov/Archives/edgar/data/1439222/000119312520128793/0001193125-20-128793-index.htm
2020-04-30S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1439222/000119312520128809/0001193125-20-128809-index.htm
2020-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520155665/0001193125-20-155665-index.htm
2020-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520155682/0001193125-20-155682-index.htm
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520167148/0001193125-20-167148-index.htm
2020-07-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520203351/0001193125-20-203351-index.htm
2020-09-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520240994/0001193125-20-240994-index.htm
2020-09-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520249634/0001193125-20-249634-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1439222/000119312520286235/0001193125-20-286235-index.htm
2018-09-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118050064/0001209191-18-050064-index.htm
2018-09-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118050631/0001209191-18-050631-index.htm
2018-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118050824/0001209191-18-050824-index.htm
2018-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118054513/0001209191-18-054513-index.htm
2018-11-064/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118057372/0001209191-18-057372-index.htm
2018-11-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118057556/0001209191-18-057556-index.htm
2018-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118059146/0001209191-18-059146-index.htm
2018-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919118064102/0001209191-18-064102-index.htm
2019-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119004950/0001209191-19-004950-index.htm
2019-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119004955/0001209191-19-004955-index.htm
2019-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119004961/0001209191-19-004961-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119007343/0001209191-19-007343-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119011483/0001209191-19-011483-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119011486/0001209191-19-011486-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119011489/0001209191-19-011489-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119011491/0001209191-19-011491-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119011494/0001209191-19-011494-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119011498/0001209191-19-011498-index.htm
2019-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119012942/0001209191-19-012942-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119013509/0001209191-19-013509-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119013515/0001209191-19-013515-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119013525/0001209191-19-013525-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119013531/0001209191-19-013531-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119013536/0001209191-19-013536-index.htm
2019-03-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119014933/0001209191-19-014933-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119016381/0001209191-19-016381-index.htm
2019-03-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119017738/0001209191-19-017738-index.htm
2019-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119020288/0001209191-19-020288-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119023072/0001209191-19-023072-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119024105/0001209191-19-024105-index.htm
2019-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119025785/0001209191-19-025785-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033614/0001209191-19-033614-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033616/0001209191-19-033616-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033618/0001209191-19-033618-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033620/0001209191-19-033620-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033622/0001209191-19-033622-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033625/0001209191-19-033625-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000120919119033626/0001209191-19-033626-index.htm
2018-11-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922218000018/0001439222-18-000018-index.htm
2019-02-1410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1439222/000143922219000004/0001439222-19-000004-index.htm
2019-05-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922219000009/0001439222-19-000009-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922219000011/0001439222-19-000011-index.htm
2019-08-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922219000017/0001439222-19-000017-index.htm
2019-10-3110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922219000021/0001439222-19-000021-index.htm
2019-11-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922219000023/0001439222-19-000023-index.htm
2019-11-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922219000025/0001439222-19-000025-index.htm
2019-12-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922219000027/0001439222-19-000027-index.htm
2019-12-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922219000028/0001439222-19-000028-index.htm
2019-12-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922219000030/0001439222-19-000030-index.htm
2020-01-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000002/0001439222-20-000002-index.htm
2020-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000003/0001439222-20-000003-index.htm
2020-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000005/0001439222-20-000005-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000006/0001439222-20-000006-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000008/0001439222-20-000008-index.htm
2020-02-1910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1439222/000143922220000014/0001439222-20-000014-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000015/0001439222-20-000015-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000016/0001439222-20-000016-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000017/0001439222-20-000017-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000018/0001439222-20-000018-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000019/0001439222-20-000019-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000020/0001439222-20-000020-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000021/0001439222-20-000021-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000022/0001439222-20-000022-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000023/0001439222-20-000023-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000024/0001439222-20-000024-index.htm
2020-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000025/0001439222-20-000025-index.htm
2020-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000026/0001439222-20-000026-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000027/0001439222-20-000027-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000028/0001439222-20-000028-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000029/0001439222-20-000029-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000030/0001439222-20-000030-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000031/0001439222-20-000031-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000032/0001439222-20-000032-index.htm
2020-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000033/0001439222-20-000033-index.htm
2020-04-3010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922220000039/0001439222-20-000039-index.htm
2020-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000041/0001439222-20-000041-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000049/0001439222-20-000049-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000050/0001439222-20-000050-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000051/0001439222-20-000051-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000052/0001439222-20-000052-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000053/0001439222-20-000053-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000054/0001439222-20-000054-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000055/0001439222-20-000055-index.htm
2020-07-3010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922220000059/0001439222-20-000059-index.htm
2020-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000061/0001439222-20-000061-index.htm
2020-10-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000143922220000063/0001439222-20-000063-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1439222/000143922220000069/0001439222-20-000069-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000156223019000005/0001562230-19-000005-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1439222/000156223020000005/0001562230-20-000005-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1439222/000162828019007955/0001628280-19-007955-index.htm
2019-04-26CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1439222/999999999719003422/9999999997-19-003422-index.htm
2019-04-26CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1439222/999999999719003444/9999999997-19-003444-index.htm
2019-07-16CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1439222/999999999719006154/9999999997-19-006154-index.htm

Agios Pharmaceuticals, Inc (AGIO) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Agios Pharmaceuticals, Inc (AGIO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1133%
Institutional Ownership: 9234%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-09-28Carman AlensonPrincipal Accounting OfficerSell152.0076.4511,620.400.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011483/0001209191-19-011483-index.htm
2020-02-16David P SchenkeinDirectorBuy8,125.00105,692.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000015/0001439222-20-000015-index.htm
2020-02-22David P SchenkeinDirectorBuy2,775.00105,933.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000022/0001439222-20-000022-index.htm
2020-04-13Christopher BowdenChief Medical OfficerBuy5,280.0010,598.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000028/0001439222-20-000028-index.htm
2019-03-01Steven L. HoerterChief Commercial OfficerSell5,000.0066.01330,050.0010,941.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119016381/0001209191-19-016381-index.htm
2019-03-04Steven L. HoerterChief Commercial OfficerSell5,000.0068.00340,000.0010,941.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119016381/0001209191-19-016381-index.htm
2019-04-01Christopher BowdenChief Medical OfficerSell5,854.0066.03386,539.6211,384.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119023072/0001209191-19-023072-index.htm
2020-05-20Christopher BowdenChief Medical OfficerBuy3,583.0035.16125,978.2811,889.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000041/0001439222-20-000041-index.htm
2019-02-16Steven L. HoerterChief Commercial OfficerBuy2,750.0011,981.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011494/0001209191-19-011494-index.htm
2019-02-16Andrew HirschChief Financial OfficerBuy2,750.0013,195.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011491/0001209191-19-011491-index.htm
2019-05-31IAN T CLARKDirectorBuy1,400.001,400.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033616/0001209191-19-033616-index.htm
2019-05-31JACQUALYN A FOUSEChief Executive OfficerBuy1,400.001,400.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033620/0001209191-19-033620-index.htm
2019-05-31Maykin HoDirectorBuy1,400.001,400.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033622/0001209191-19-033622-index.htm
2019-05-31Paul J ClancyDirectorBuy1,400.001,400.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033614/0001209191-19-033614-index.htm
2019-01-20Andrew HirschChief Financial OfficerBuy15,000.0015,000.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119004961/0001209191-19-004961-index.htm
2019-01-20Steven L. HoerterChief Commercial OfficerBuy15,000.0015,000.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119004955/0001209191-19-004955-index.htm
2020-02-16Andrew HirschChief Financial OfficerBuy2,750.0015,127.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000016/0001439222-20-000016-index.htm
2020-02-04Christopher BowdenChief Medical OfficerBuy8,526.0035.16299,774.1615,841.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000005/0001439222-20-000005-index.htm
2019-03-01Steven L. HoerterChief Commercial OfficerBuy5,000.0039.76198,800.0015,941.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119016381/0001209191-19-016381-index.htm
2019-03-04Steven L. HoerterChief Commercial OfficerBuy5,000.0039.76198,800.0015,941.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119016381/0001209191-19-016381-index.htm
2020-02-04Christopher BowdenChief Medical OfficerSell14,191.0050.03709,962.961,650.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000005/0001439222-20-000005-index.htm
2020-02-04Christopher BowdenChief Medical OfficerSell35,447.0050.101,776,025.851,650.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000005/0001439222-20-000005-index.htm
2020-02-11Christopher BowdenChief Medical OfficerSell621.0050.0231,063.231,650.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000006/0001439222-20-000006-index.htm
2020-02-13Christopher BowdenChief Medical OfficerSell7,100.0050.16356,111.861,650.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000008/0001439222-20-000008-index.htm
2019-03-15Christopher BowdenChief Medical OfficerBuy10,000.0035.16351,600.0017,238.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119020288/0001209191-19-020288-index.htm
2019-04-01Christopher BowdenChief Medical OfficerBuy10,000.0035.16351,600.0017,238.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119023072/0001209191-19-023072-index.htm
2020-02-22Andrew HirschChief Financial OfficerBuy3,333.0017,574.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000024/0001439222-20-000024-index.htm
2019-11-12CORP /DE/ CELGENE10% Share HolderBuy403,225.0031.0012,499,975.001,777,824.00https://www.sec.gov/Archives/edgar/data/1439222/000110465919064171/0001104659-19-064171-index.htm
2019-12-26Carman AlensonPrincipal Accounting OfficerSell2,950.0050.09147,765.50184.00https://www.sec.gov/Archives/edgar/data/1439222/000143922219000030/0001439222-19-000030-index.htm
2020-02-20Carman AlensonPrincipal Accounting OfficerSell2,427.0053.37129,528.99184.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000020/0001439222-20-000020-index.htm
2020-02-26Carman AlensonPrincipal Accounting OfficerSell472.0047.1222,240.64184.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000025/0001439222-20-000025-index.htm
2020-03-02Carman AlensonPrincipal Accounting OfficerSell345.0047.3016,318.50184.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000027/0001439222-20-000027-index.htm
2020-09-02Carman AlensonPrincipal Accounting OfficerSell250.0039.939,982.50184.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000061/0001439222-20-000061-index.htm
2019-05-31David ScaddenDirectorBuy1,400.001,971.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033626/0001209191-19-033626-index.htm
2020-04-13Andrew HirschChief Financial OfficerBuy5,387.0021,905.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000031/0001439222-20-000031-index.htm
2018-09-12JOHN MARAGANOREDirectorSell14,162.0071.741,015,981.8822,047.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118050824/0001209191-18-050824-index.htm
2020-02-11Christopher BowdenChief Medical OfficerBuy621.0035.1621,834.362,271.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000006/0001439222-20-000006-index.htm
2018-12-21Scott BillerChief Scientific OfficerBuy20,500.002.3447,918.7524,637.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118064102/0001209191-18-064102-index.htm
2020-04-22Andrew HirschChief Financial OfficerBuy5,893.0026,199.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000033/0001439222-20-000033-index.htm
2019-02-27Scott BillerChief Scientific OfficerSell9,000.0065.00585,000.0026,511.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119014933/0001209191-19-014933-index.htm
2019-03-05Scott BillerChief Scientific OfficerSell200.0068.2213,644.0026,511.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119017738/0001209191-19-017738-index.htm
2019-04-05Scott BillerChief Scientific OfficerSell599.0068.1240,803.8826,511.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119024105/0001209191-19-024105-index.htm
2019-03-05Scott BillerChief Scientific OfficerSell2,600.0067.73176,098.0026,711.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119017738/0001209191-19-017738-index.htm
2019-03-05Scott BillerChief Scientific OfficerBuy428.0031.6413,541.9226,939.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119017738/0001209191-19-017738-index.htm
2019-04-05Scott BillerChief Scientific OfficerSell2,401.0067.61162,331.6127,110.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119024105/0001209191-19-024105-index.htm
2019-02-16Scott BillerChief Scientific OfficerBuy2,750.0027,387.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011486/0001209191-19-011486-index.htm
2019-02-27Scott BillerChief Scientific OfficerBuy1,766.000.47830.0228,277.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119014933/0001209191-19-014933-index.htm
2019-03-05Scott BillerChief Scientific OfficerSell200.0066.4513,290.0029,311.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119017738/0001209191-19-017738-index.htm
2019-03-05Scott BillerChief Scientific OfficerBuy2,572.0039.76102,262.7229,511.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119017738/0001209191-19-017738-index.htm
2019-04-05Scott BillerChief Scientific OfficerBuy3,000.0039.76119,280.0029,511.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119024105/0001209191-19-024105-index.htm
2020-05-29JOHN MARAGANOREDirectorBuy1,878.0030,172.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000050/0001439222-20-000050-index.htm
2019-02-27Scott BillerChief Scientific OfficerBuy4,154.009.0537,593.7032,431.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119014933/0001209191-19-014933-index.htm
2020-05-29IAN T CLARKDirectorBuy1,878.003,278.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000051/0001439222-20-000051-index.htm
2020-05-29Maykin HoDirectorBuy1,878.003,278.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000049/0001439222-20-000049-index.htm
2020-05-29Paul J ClancyDirectorBuy1,878.003,278.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000053/0001439222-20-000053-index.htm
2019-06-11Scott BillerChief Scientific OfficerBuy7,218.002.3416,872.0833,729.00https://www.sec.gov/Archives/edgar/data/1439222/000162828019007955/0001628280-19-007955-index.htm
2019-02-27Scott BillerChief Scientific OfficerBuy3,080.0031.6497,451.2035,511.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119014933/0001209191-19-014933-index.htm
2019-05-31Kaye I Foster-CheekDirectorBuy1,400.003,600.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033618/0001209191-19-033618-index.htm
2018-09-11JOHN MARAGANOREDirectorSell2,400.0073.82177,168.0036,209.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118050824/0001209191-18-050824-index.htm
2020-02-05Christopher BowdenChief Medical OfficerBuy35,447.0035.161,246,316.5237,097.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000005/0001439222-20-000005-index.htm
2019-05-31JOHN MARAGANOREDirectorBuy1,400.0037,609.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119033625/0001209191-19-033625-index.htm
2020-02-16Carman AlensonPrincipal Accounting OfficerBuy2,800.003,774.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000019/0001439222-20-000019-index.htm
2019-02-21Carman AlensonPrincipal Accounting OfficerBuy3,300.003,812.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119012942/0001209191-19-012942-index.htm
2020-05-29David ScaddenDirectorBuy1,878.003,849.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000054/0001439222-20-000054-index.htm
2018-09-11JOHN MARAGANOREDirectorSell11,155.0072.52808,960.6038,609.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118050824/0001209191-18-050824-index.htm
2019-11-13JACQUALYN A FOUSEChief Executive OfficerBuy40,322.0031.001,249,982.0041,722.00https://www.sec.gov/Archives/edgar/data/1439222/000143922219000025/0001439222-19-000025-index.htm
2020-02-16Christopher BowdenChief Medical OfficerBuy2,750.004,400.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000018/0001439222-20-000018-index.htm
2018-10-05Scott BillerChief Scientific OfficerSell21.0071.771,507.1750,932.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118054513/0001209191-18-054513-index.htm
2018-11-05Scott BillerChief Scientific OfficerSell100.0071.427,142.0050,932.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118057556/0001209191-18-057556-index.htm
2018-10-05Scott BillerChief Scientific OfficerSell1,100.0071.0578,155.0050,953.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118054513/0001209191-18-054513-index.htm
2018-11-05Scott BillerChief Scientific OfficerSell700.0070.2349,161.0051,032.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118057556/0001209191-18-057556-index.htm
2018-11-05Scott BillerChief Scientific OfficerSell2,200.0069.44152,768.0051,732.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118057556/0001209191-18-057556-index.htm
2018-10-05Scott BillerChief Scientific OfficerSell979.0069.4768,011.1352,053.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118054513/0001209191-18-054513-index.htm
2018-10-05Scott BillerChief Scientific OfficerSell900.0068.5661,704.0053,032.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118054513/0001209191-18-054513-index.htm
2018-10-05Scott BillerChief Scientific OfficerBuy3,000.009.0527,150.0053,932.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118054513/0001209191-18-054513-index.htm
2018-11-05Scott BillerChief Scientific OfficerBuy3,000.009.0527,150.0053,932.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118057556/0001209191-18-057556-index.htm
2020-04-13JACQUALYN A FOUSEChief Executive OfficerBuy12,379.0054,101.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000030/0001439222-20-000030-index.htm
2020-05-29Kaye I Foster-CheekDirectorBuy1,878.005,478.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000052/0001439222-20-000052-index.htm
2020-04-13Bruce CarChief Scientific OfficerBuy6,874.006,874.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000029/0001439222-20-000029-index.htm
2020-02-22Christopher BowdenChief Medical OfficerBuy3,333.006,914.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000023/0001439222-20-000023-index.htm
2019-01-20Christopher BowdenChief Medical OfficerBuy6,265.007,189.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119004950/0001209191-19-004950-index.htm
2019-03-15Christopher BowdenChief Medical OfficerSell1,300.0064.6484,032.007,238.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119020288/0001209191-19-020288-index.htm
2019-04-01Christopher BowdenChief Medical OfficerSell100.0068.726,872.007,238.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119023072/0001209191-19-023072-index.htm
2018-09-05David P SchenkeinChief Executive OfficerBuy72,619.002.34169,928.4672,619.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118050064/0001209191-18-050064-index.htm
2019-04-01Christopher BowdenChief Medical OfficerSell1,500.0068.09102,135.007,338.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119023072/0001209191-19-023072-index.htm
2018-09-05David P SchenkeinChief Executive OfficerBuy2,500.0031.6479,100.0075,119.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118050064/0001209191-18-050064-index.htm
2019-02-16Carman AlensonPrincipal Accounting OfficerBuy790.00790.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011483/0001209191-19-011483-index.htm
2019-02-16Christopher BowdenChief Medical OfficerBuy2,750.008,013.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011489/0001209191-19-011489-index.htm
2020-05-20Christopher BowdenChief Medical OfficerSell3,583.0050.01179,200.168,306.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000041/0001439222-20-000041-index.htm
2018-09-10David P SchenkeinChief Executive OfficerBuy8,730.0031.64276,217.2083,849.00https://www.sec.gov/Archives/edgar/data/1439222/000120919118050631/0001209191-18-050631-index.htm
2020-04-13Jonathan BillerChief Legal OfficerBuy8,523.008,523.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000032/0001439222-20-000032-index.htm
2019-03-15Christopher BowdenChief Medical OfficerSell8,700.0064.09557,583.008,538.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119020288/0001209191-19-020288-index.htm
2020-02-22Carman AlensonPrincipal Accounting OfficerBuy691.00875.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000021/0001439222-20-000021-index.htm
2020-02-13Christopher BowdenChief Medical OfficerBuy7,100.0035.16249,636.008,750.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000008/0001439222-20-000008-index.htm
2019-04-01Christopher BowdenChief Medical OfficerSell2,546.0066.85170,200.108,838.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119023072/0001209191-19-023072-index.htm
2019-02-16David P SchenkeinDirectorBuy8,125.0091,974.00https://www.sec.gov/Archives/edgar/data/1439222/000120919119011498/0001209191-19-011498-index.htm
2020-02-16Carman AlensonPrincipal Accounting OfficerBuy790.00974.00https://www.sec.gov/Archives/edgar/data/1439222/000143922220000019/0001439222-20-000019-index.htm
2019-11-13David P SchenkeinDirectorBuy8,064.0031.00249,984.0097,567.00https://www.sec.gov/Archives/edgar/data/1439222/000143922219000023/0001439222-19-000023-index.htm